Florbenazine F18

N/A

Report date: 2025/12/18 20:00:07
NME

Base Information

Drug NameFlorbenazine F18
Drug Alias Name8F-FP-Dihydrotatetrabenazine[18F]FP-(+)- DTBZ(+)-18FP-DTBZ[18F]AV- 133[18F]DTBZ +[7] 
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionSynaptic vesicular amine transporter inhibitors
TargetsSynaptic vesicular amine transporter
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Alzheimer Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of MichiganUniversity Of PennsylvaniaAvid Radiopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Michael J. Fox Foundation For Parkinson'S Research
Inactive CompaniesColumbia UniversityChang Gung Memorial HospitalAvid Radiopharmaceuticals Inc
Active IndicationsParkinson Disease
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Alzheimer Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A